877P Exploratory Efficacy and Translational Results from the Safety Run in of AHEAD-MERIT, a Phase II Trial of First Line Pembrolizumab Plus the Fixed-Antigen Cancer Vaccine BNT113 in Advanced HPV16+ HNSCC
Annals of Oncology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要